Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 100 shares, a decline of 75.0% from the December 15th total of 400 shares. Based on an average daily volume of 3,100 shares, the short-interest ratio is presently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

HROWM stock traded up $0.18 during mid-day trading on Tuesday, reaching $26.94. 2,544 shares of the stock traded hands, compared to its average volume of 4,368. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52-week low of $25.29 and a 52-week high of $27.72. The stock’s fifty day moving average is $26.26 and its 200-day moving average is $26.36.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be given a $0.7422 dividend. The ex-dividend date is Wednesday, January 15th. This represents a $2.97 annualized dividend and a dividend yield of 11.02%.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.